Join the Tirosint group to help and get support from people like you.
Tirosint News
FDA Upgrades Recall on 160,000+ Bottles of Thyroid Medication
THURSDAY, July 24, 2025 — The U.S. Food and Drug Administration (FDA) has upgraded a recall of a commonly prescribed thyroid medication due to what it described as "subpotent" active ingredients. The ...
Could the Common Thyroid Medicine Levothyroxine Weaken Bones?
MONDAY, Nov. 25, 2024 – New research suggests that a thyroid medication often prescribed to older Americans may be linked to a common problem in old age – bone loss. Levothyroxine is a synthetic...
RSNA: Levothyroxine Tied to Bone Loss Over Time in Older Adults
MONDAY, Nov. 25, 2024 – Levothyroxine (LT4) use is associated with longitudinal loss of bone mass and density in older adults, according to a study scheduled to be presented at the annual meeting of...
FDA Medwatch Alert: IBSA Pharma Inc. Issues Voluntary Nationwide Recall of Select Lots of Tirosint®-Sol (levothyroxine sodium) Oral Solution Due to Subpotency
February 01, 2023 – IBSA Pharma Inc. is voluntarily recalling 27 lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution to the consumer level. This voluntary recall has been initiated ...
Further information
Related condition support groups
Hashimoto's Disease, Underactive Thyroid, Hypothyroidism, Hypothyroidism - After Thyroid Removal, TSH Suppression